Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. ACN
5. IBM
6. META
7. SPY
8. NVDA
9. PRIM
10. PFE

Go back to Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business Update

Lexicon Pharma (LXRX) Misses Q2 EPS by 4c, Revenues Beat

July 30, 2020 7:28 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.65), $0.04 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $8.83... More